IRIS
MADEDDU, Giordano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.988
AS - Asia 7.906
EU - Europa 6.564
SA - Sud America 4.518
Continente sconosciuto - Info sul continente non disponibili 591
AF - Africa 317
OC - Oceania 27
AN - Antartide 1
Totale 38.912
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.610
BR - Brasile 4.037
SG - Singapore 3.509
IT - Italia 2.812
CN - Cina 1.886
UA - Ucraina 1.028
DE - Germania 703
HK - Hong Kong 666
VN - Vietnam 655
FR - Francia 457
FI - Finlandia 297
GB - Regno Unito 275
SE - Svezia 203
AR - Argentina 166
CA - Canada 157
IN - India 154
NL - Olanda 149
BD - Bangladesh 135
RU - Federazione Russa 133
TR - Turchia 127
IQ - Iraq 122
MX - Messico 118
EC - Ecuador 89
ZA - Sudafrica 88
PK - Pakistan 73
PL - Polonia 71
UZ - Uzbekistan 70
ES - Italia 67
JP - Giappone 67
MA - Marocco 67
CZ - Repubblica Ceca 60
VE - Venezuela 57
CO - Colombia 55
RO - Romania 46
NP - Nepal 43
BE - Belgio 42
ID - Indonesia 40
TN - Tunisia 40
AE - Emirati Arabi Uniti 39
KR - Corea 39
PY - Paraguay 34
KE - Kenya 32
AT - Austria 31
SA - Arabia Saudita 30
CH - Svizzera 29
JO - Giordania 28
AU - Australia 26
AZ - Azerbaigian 26
CL - Cile 23
KZ - Kazakistan 23
RS - Serbia 23
UY - Uruguay 23
IE - Irlanda 22
PE - Perù 22
IL - Israele 21
LT - Lituania 20
JM - Giamaica 19
KG - Kirghizistan 19
DO - Repubblica Dominicana 17
PH - Filippine 17
AL - Albania 16
CR - Costa Rica 16
MY - Malesia 16
DZ - Algeria 15
EG - Egitto 15
OM - Oman 15
PS - Palestinian Territory 15
SN - Senegal 15
BG - Bulgaria 14
EU - Europa 14
IR - Iran 14
LB - Libano 13
PA - Panama 13
XK - ???statistics.table.value.countryCode.XK??? 10
HN - Honduras 9
HU - Ungheria 9
AM - Armenia 8
BO - Bolivia 8
BY - Bielorussia 8
MD - Moldavia 8
ET - Etiopia 7
GR - Grecia 7
MK - Macedonia 6
NG - Nigeria 6
PT - Portogallo 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BN - Brunei Darussalam 5
LU - Lussemburgo 5
NI - Nicaragua 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
AO - Angola 4
CI - Costa d'Avorio 4
GT - Guatemala 4
LY - Libia 4
TH - Thailandia 4
GA - Gabon 3
GD - Grenada 3
KH - Cambogia 3
Totale 38.284
Salva come PNG Salva come JPEG
Città #
Dallas 9.387
Singapore 1.974
Chandler 1.265
San Jose 1.223
Ashburn 693
Hong Kong 659
Jacksonville 579
Beijing 473
Council Bluffs 428
Princeton 396
Columbus 385
New York 331
São Paulo 263
Rome 257
Lauterbourg 241
Ho Chi Minh City 213
Munich 198
Nanjing 195
Los Angeles 192
Dearborn 190
Milan 185
Santa Clara 176
Hanoi 164
Shanghai 156
Wilmington 156
Sassari 152
Rio de Janeiro 131
Helsinki 128
Boardman 122
Belo Horizonte 114
Ann Arbor 106
Nanchang 82
The Dalles 81
Brasília 78
Curitiba 71
Shenyang 70
Naples 66
Tashkent 60
Campinas 59
Orem 58
Tianjin 58
Tokyo 58
Cagliari 57
Brno 56
Porto Alegre 56
Warsaw 55
Florence 54
Frankfurt am Main 53
Montreal 51
Denver 50
San Francisco 50
Buffalo 48
Woodbridge 48
Atlanta 47
Brooklyn 44
Toronto 44
Changsha 43
Hebei 43
London 43
Baghdad 42
Johannesburg 42
Brussels 41
Nuremberg 40
Salvador 40
Fortaleza 39
Palermo 39
Turin 39
Phoenix 38
Chennai 37
Guarulhos 37
Guayaquil 37
Chicago 36
Jinan 35
Seoul 35
Mexico City 34
Manchester 33
Poplar 32
São José dos Campos 32
Dhaka 31
Goiânia 31
Zhengzhou 31
Da Nang 30
Guangzhou 30
Houston 30
São Bernardo do Campo 30
Turku 30
Amsterdam 29
Nairobi 28
Haiphong 27
Istanbul 27
Jiaxing 27
Santo André 27
Sorocaba 27
Amman 26
Lahore 26
Ningbo 26
Recife 26
Ribeirão Preto 26
Bologna 25
Norwalk 25
Totale 24.038
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 2.067
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 843
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 659
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 651
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 574
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 540
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 532
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study 435
PARVOVIRUS B19 E POLIMIALGIA REUMATICA: THE BUTTERFLY EFFECT 394
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 284
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 284
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 280
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 268
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics) 268
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 264
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 258
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 252
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 248
Fluoroquinolones and Biofilm: A Narrative Review 242
Efficacy and tolerability of antiretroviral therapy: focus on people with HIV or on PrEP 229
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 227
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV 223
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 221
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 219
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 214
A case of vasculitis-like skin eruption associated with COVID-19 212
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 208
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 200
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 198
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 196
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 192
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 189
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 185
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 184
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. 180
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 177
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 176
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 175
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 175
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 174
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 173
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 172
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 169
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 168
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 167
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 163
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 162
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 162
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 160
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 159
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 158
Adverse skin reactions in course of combined antiretroviral therapy 158
Trends in the European HIV/AIDS epidemic: a perspective from Italy 158
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 156
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 155
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 154
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 152
Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s 152
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 152
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 152
Meningite linfomatosa in un paziente con linfoma plasmoblastico del cavo orale HIV-relato: ruolo della citarabina liposomiale. 151
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 150
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 149
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 148
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 148
QuantiFERON TB Gold: a new method for latent tuberculosis infection 147
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 147
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 145
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 144
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 144
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 143
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 143
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 143
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 142
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 142
Bacterial community-acquired pneumonia in HIV-infected patients 142
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 142
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 140
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 140
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 140
Hepatic echinococcosis: clinical and therapeutic aspects. 139
Utilizzo di EVG/COBI/FTC/TDF in una paziente con viremia elevata e cirrosi HCV-correlata 138
Kidney disease in HIV-infected patients. 137
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 137
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 136
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 135
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 135
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 135
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 135
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 134
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 134
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 132
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. 132
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy. 132
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 131
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 131
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 130
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 129
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 129
The HIV treatment and care cascade in Italy: successes and disparities 129
Totale 22.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022979 0 29 26 26 26 32 40 63 83 72 143 439
2022/20232.522 239 209 68 414 208 404 37 274 402 47 130 90
2023/20241.209 139 72 56 40 293 114 35 79 17 48 101 215
2024/20259.092 150 144 492 308 492 405 674 1.560 2.882 1.231 517 237
2025/202619.005 655 3.112 7.385 1.796 1.431 625 1.840 371 580 689 338 183
2026/20271.286 484 802 0 0 0 0 0 0 0 0 0 0
Totale 38.912